UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Tiffany Glocke, PharmD

Title(s)Associate Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
ORCID ORCID Icon0000-0001-6733-3123 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    University of California, San Francisco2016Apples of Preceptor Award
    University of California, San Francisco2014Long Award for Excellence in Teaching
    UC Davis Medical Center2012Pharmacy Resident of the Year
    American Society of Health-System Pharmacists2011Student Leadership Award
    Indiana Pharmacists Alliance2011Joseph E. McSoley Award

    Collapse Overview 
    Collapse Overview
    Dr. Tiffany Pon is an Associate Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the University of California, San Francisco. Her clinical practice site is at the University of California, Davis Medical Center (UCDMC) where she provides clinical services in internal medicine. She is also the Program Director for the Greater Sacramento Area Experiential Education site. Research interests involve anticoagulation, including therapeutic dosing of low-molecular-weight-heparins in special populations, anticoagulation reversal, and heparin-induced thrombocytopenia. She is also passionate about leadership within the profession and is an active member of the American College of Clinical Pharmacy.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pon TK, Wessel N, Cagonot V, Delmonte R, Roach D, Finta L. Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section. Int J Clin Pharm. 2019 Feb; 41(1):264-271. PMID: 30661217.
      View in: PubMed
    2. Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 May; 45(4):536-542. PMID: 29574610.
      View in: PubMed
    3. Phillips HJ, Dangler A, Klem PM, Chu F, Pon T, Liewer S, Thompson Bastin ML, Halfpap JJ, Fish J, Stun L, Varughese CA. Preceptor development: Responses to frequently asked questions from preceptors in academic hospitals. Am J Health Syst Pharm. 2016 May 01; 73(9):e261-6. PMID: 27099334.
      View in: PubMed
    4. Dager WE, Tsu LV, Pon TK. Considerations for Systemic Anticoagulation in ESRD. Semin Dial. 2015 Jul-Aug; 28(4):354-62. PMID: 25951901.
      View in: PubMed
    5. Cutler TW, Chuang A, Huynh TD, Witt RG, Branch J, Pon T, White R. A retrospective descriptive analysis of patient adherence to dabigatran at a large academic medical center. J Manag Care Spec Pharm. 2014 Oct; 20(10):1028-34. PMID: 25278325.
      View in: PubMed
    6. Pon TK, Dager WE, Roberts AJ, White RH. Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients. Thromb Res. 2014 Jun; 133(6):1023-8. PMID: 24718051.
      View in: PubMed